AVPT vs CRL · P/E 54, rev $241.7M vs rev $2.00B
Avepoint Inc (AVPT) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Avepoint Inc (AVPT) is a software - infrastructure company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported AVPT revenue for 2026-06-30 was $241.7M. Net income was $42.8M. AVPT currently screens at market cap $2.28B and trailing P/E 53.7.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
AVPT currently screens at market cap $2.28B and trailing P/E 53.7. CRL currently screens at market cap $7.78B.
Not investment advice. Open the AVPT and CRL stock pages for the full models.
Not investment advice.